Europe’s medicines regulator said on Thursday it had added a rare nerve-degenerating disorder, Guillain-Barré syndrome, as a possible rare side effect from Johnson & Johnson’s COVID-19 vaccine after it reviewed 108 cases reported worldwide.
“After assessing the available data, PRAC considered that a causal relationship between COVID-19 vaccine Janssen and GBS is possible,” the European Medicines Agency said, referring to its safety committee, PRAC.
Barclays raises this year’s oil price forecast by $3-5 per barrelThe oil market’s supply and demand dynamics point to a slow grind higher in prices over the next few months, Barclays said on Thursday, as it raised ... Energy
Israel to reimpose COVID-19 ‘Green Pass’ as Delta variant hitsIsrael announced plans on Thursday to allow only people who are deemed immune to COVID-19 or have recently tested negative to enter some public spaces ... Coronavirus
US to impose sanctions on Cuban officials over crackdown on protestsThe Biden administration plans to announce US sanctions on Thursday against several Cuban officials over their role in a crackdown on anti-government ... World News